Posts by vivian
Structural Biology: The Atomic Spyglass Revolutionizing Medicine
For decades, KRAS was considered one of oncology’s most difficult drug targets. In 2013, crystallographic studies revealed a previously unrecognized pocket beneath the switch-II region of KRAS G12C, providing a structural basis for mutant-selective inhibitor design. Years of medicinal chemistry and clinical development followed, culminating in the first FDA approval of a KRAS G12C inhibitor in 2021. This landmark case illustrates how structural biology can transform a challenging disease target into a clinically actionable opportunity. This is not an isolated…
Beyond Safety: Strategic In Vitro Testing for Targeted Cosmetic Efficacy Claims
The global cosmetics industry is undergoing a profound transformation, driven by increasingly sophisticated regulatory frameworks and consumers who demand scientifically proven efficacy. For R&D teams, the core challenge in cosmetics testing is no longer solely about confirming a product is safe—it is about strategically designing a program that provides mechanistic evidence for specific claims and accelerates time-to-market. This requires a mechanism-driven, tiered approach integrating advanced in vitro methodologies. Implementing comprehensive cosmetics testing strategies early in the R&D pipeline has become the…
Decoding Life’s Molecular Switches: How Structural Biology Is Illuminating the Path to Modern Medicine
Introduction Why do some drugs successfully treat diseases while others—seemingly perfect molecules—fail in clinical trials? The answers often lie in a microscopic world tens of thousands of times smaller than the width of a human hair, hidden deep inside our cells.In this world, proteins play starring roles. They are the messengers that transmit signals, and the gateways that viruses exploit to break in. For decades, scientists could only infer the shapes of these proteins through indirect experiments—like trying to determine…